Nature's Sunshine Products (NATR) Tops Q4 EPS by 2c, Beats on Revenue; Offers FY26 Revenue Guidance

Nature's Sunshine Products (NASDAQ: NATR) reported Q4 EPS of $0.23, $0.02 better than the analyst estimate of $0.21. Revenue for the quarter came in at $123.8 million versus the consensus estimate of $118.82 million.

GUIDANCE:

Nature's Sunshine Products sees FY2026 revenue of $500-515 million, versus the consensus of $495 million.

For earnings history and earnings-related data on Nature's Sunshine Products (NATR) click here.

You May Also Be Interested In

• EyePoint Pharmaceuticals (EYPT) call put ratio 1.4 calls to 1 put as share price up 8.9%
• BT Brands posts Q2 profit, cuts costs as restaurant sales dip
• uCloudlink Group Inc. (UCL) Misses Q2 EPS by 1c ; Offers Guidance